Strongyloides stercoralis hyperinfection in a diabetic patient: Case report

Tropical Biomedicine

Volumn 27, Issue 1, 2010, Pages 115-119

  Azira, N M S ^a   Zeehaida, M ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

AGED; ANIMAL; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DIABETES MELLITUS; HUMAN; MALE; PARASITOLOGY; PEMPHIGUS; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

AGED; ANIMALS; AZATHIOPRINE; DIABETES MELLITUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PEMPHIGUS; PREDNISOLONE; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

EID: 77949635453     PISSN: 01275720     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Armignacco, O., Capecchi, A., De Mori, P. & Grillo, L.R. (1989). Strongyloides stercoralis hyperinfection and the acquired immunodeficiency syndrome. American Journal of Medicine 86: 258.
2. Blatt, J.M. & Cantos, G.A. (2003). Evaluation of techniques for the diagnosis of Strongyloides stercoralis in Human Immunodeficiency Virus (HIV) positive and HIV negative individuals in the city of Itajaí, Brazil. The Brazilian Journal of Infectious Diseases 7(6): 402-408.
3. Davidson, R.A., Fletcher, R.H. & Chapman, L.E. (1984). Risk factors for Strongyloidiasis: A case-control study. Archcieve of Internal Medicine 144: 321-324.
4. nd Edition. World Health Organization, Geneva. Chapter 5, pg 156-157.
5. Fardet, L., Ge'ne'reau, T., Poirot, J., Guidet, B., Kettaneh, A. & Cabane, J. (2007). Severe strongyloidiasis in corticosteroid- treated patients: Case series and literature review. Journal of Infection 54: 18-27.
6. Gotuzzo, E., Terashima, A., Alvarez, H., Tello, R., Infante, R., Watts, D.M. & Freedman, D.O. (1999). Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. American Journal of Tropical Medical Hygiene 60: 146-149.
7. Keiser, P. & Nutman, T. (2004). Strongyloides stercoralis in the immunocompromised population. Clinical Microbiology Review 17(1): 208-17.
8. Marathe, A. & Date, V. (2008). Strongyloides stercoralis Hyperinfection in an Immunocompetent Patient with Extreme Eosinophilia. Journal of Parasitology 94(3): 759-760.
9. Marcosa, L.A., Terashimab, A., DuPonta H. L. & Gotuzzo, E. (2008). Strongyloides hyperinfection syndrome: an emerging global infectious disease. Transactions of the Royal Society of Tropical Medicine and Hygiene 102: 314-318.
10. Mora, C.S., Segami, M.I. & Hidalgo J. A. (2006). Strongyloides stercoralis hyperinfection in Systemic Lupus Erythematosus and the Antiphospholipid Syndrome. Seminars in Arthritis and Rheumatism 36: 135-143.
11. Tsai, H.C., Lee, S.S., Liu, Y.C., Lin, W.R., Huang, C.K., Chen, Y.S., Wann, S.R., Tsai, T.H., Lin, H.H., Yen, M.Y., Yen, C.M. & Chen, E.R. (2002). Clinical manifestations of Strongyloidiasis in Southern Taiwan. Journal of Microbiology, Immunology and Infection 35(1): 29-36.
12. Siddiqui, A.A. & Berk, S.L. (2001). Diagnosis of Strongyloides stercoralis infection. Clinical Infectious Disease 33: 1040-1047.